Sensitive ASX Announcement

CHM ceases enrolment in Phase 1 trial and Company update

Published: 19/08/26, 09:08am (AEST)•4 pages
Chimeric Therapeutics
CHM:ASX•Healthcare

Recent CHM Announcements

Price Sensitive only